Welcome to our dedicated page for Solesence news (Ticker: SLSN), a resource for investors and traders seeking the latest updates and insights on Solesence stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Solesence's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Solesence's position in the market.
Solésence (NASDAQ:SLSN) announced significant leadership changes as part of its strategic transformation. Kevin Cureton has been promoted to President and CEO, while Laura Riffner joins as CFO. Current CEO Jess Jankowski will transition to Board Advisor until his retirement on November 21, 2025.
These appointments follow Solésence's recent rebranding from Nanophase Technologies and uplisting to Nasdaq in early 2025. The company, which transformed from an advanced materials company to a skin health innovator, specializes in mineral-based sun protection and beauty science solutions.
Riffner brings over 35 years of finance experience, including significant tenure as CFO at Nagase America. The leadership changes aim to build on the company's momentum in delivering skin care, sun care, and color cosmetics products globally.
Solésence (NASDAQ:SLSN) reported strong financial results for Q2 2025, with revenue surging 56% to $20.4 million compared to Q2 2024. The company achieved a net income of $2.7 million, which includes a $1.2 million Employee Retention Credit.
Operational highlights include significant volume growth, with shipments up 102% and production volume increasing 127% year-over-year. The company expanded its debt facilities, increasing maximum borrowing capacity from $14.2 million to $23.0 million and extending loan maturity dates to April 2027.
The company maintained a stable gross margin of 29% and was added to the Russell 3000® and Russell 2000® indexes, marking significant institutional recognition.
Solésence (Nasdaq: SLSN), a leader in scientifically-driven healthcare solutions for beauty and life science categories, has scheduled its second quarter 2025 financial results announcement for Thursday, July 31, 2025, after market close.
The company will host a conference call and webcast on the same day at 4:00 p.m. CDT (5:00 p.m. EDT). The call will feature presentations from President & CEO Jess Jankowski and COO Kevin Cureton. Participants can access the event through the company's investor relations website or register for dial-in access.
Solésence (Nasdaq: SLSN), a healthcare solutions provider specializing in beauty and life science, has announced its upcoming inclusion in both the Russell 3000® and Russell 2000® Indexes, effective June 30, 2025. This milestone follows the company's recent Nasdaq uplisting and is part of the 2025 Russell indexes reconstitution.
The inclusion is based on FTSE Russell's objective market-capitalization rankings, which capture the 4,000 largest US stocks as of April 30. This development is particularly significant as approximately $10.6 trillion in assets are benchmarked against Russell US indexes, potentially increasing Solésence's visibility among institutional investors.
Solésence (Nasdaq: SLSN), a leader in scientifically-driven health care solutions focusing on beauty and life science categories, has scheduled its first quarter 2025 financial results announcement and conference call.
Key Details:
- Results Release: Monday, May 5, 2025, after market close
- Conference Call Time: 4:00 p.m. CDT / 5:00 p.m. EDT
- Key Speakers: Jess Jankowski (President & CEO) and Kevin Cureton (Chief Operating Officer)
Participants can access the conference call through multiple channels:
- Webcast: Available via media server link
- Dial-in: Registration required for personalized PIN
- Company Website: Accessible through investor relations page
Interested parties are advised to join the call at least five minutes before the start time. The company has provided convenient registration options, including an automatic dial-out feature once the conference begins.
FAQ
What is the current stock price of Solesence (SLSN)?
What is the market cap of Solesence (SLSN)?
